Filter
673
Text search:
Stop
TB
Partnership,
World
Health
Organization
Featured
Recommendations
51
New Publications
186
Language
Document type
No document type
496
Studies & Reports
73
Guidelines
48
Strategic & Response Plan
23
Manuals
21
Fact sheets
6
Training Material
4
Brochures
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
26
Kenya
21
India
20
Global
19
Nepal
18
Eastern Europe
18
Rwanda
15
Bangladesh
14
Liberia
13
Uganda
13
Zambia
13
Ethiopia
12
Asia
12
Tanzania
11
South Africa
11
Myanmar / Burma
11
Cambodia
10
Malawi
9
Nigeria
8
Sierra Leone
7
Ukraine
7
Latin America and the Carribbean
7
Ghana
6
Philippines
6
Mozambique
6
Botswana
6
Indonesia
5
South–East Asia Region
5
Senegal
4
Zimbabwe
4
Namibia
4
Africa
4
Pakistan
3
Germany
3
Lesotho
3
Timor Leste/ East Timor
3
Russia
3
Guinea
2
Congo, Democratic Republic of
2
South Sudan
2
Thailand
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Sri Lanka
2
Bhutan
2
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Afghanistan
1
Syria
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Dominican Republic
1
Burundi
1
Honduras
1
El Salvador
1
Guatemala
1
Nicaragua
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
North Korea
1
Albania
1
Armenia
1
Southern Africa
1
Laos
1
Tajikistan
1
Bulgaria
1
Vietnam
1
Maldives
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
243
Clinical Guidelines
43
Public Health
22
Women & Child Health
11
Pharmacy & Technologies
11
Key Resources
10
Capacity Building
2
Toolboxes
TB
270
HIV
90
COVID-19
16
Health Financing Toolbox
15
Polio
14
AMR
12
NTDs
9
Caregiver
8
Ebola & Marburg
7
Conflict
6
Refugee
6
Global Health Education
6
Pharmacy
6
Disability
5
Natural Hazards
5
Rapid Response
4
Planetary Health
3
NCDs
3
Malaria
3
Mental Health
2
Cholera
1
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrant
...
Stop TB Communicable Diseases
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and a
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB
...
This document is an evidence-based policy for the implementation of sound tuberculosis (TB) infection control by all stake- holders. It recommends a combination of measures aimed at reducing the risk of TB
...
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guide
...
Key populations brief.
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Chapter 8, Prison and Health, published
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country
...